NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

dennisdave,

What you point out comes down to what I have been saying all along about FDA. They use the word “should” to mean suggested or recommended, but not required so technically NWBO’s data could be submitted and be considered fairly apart from what is suggested. The issue is that those who vote on approvals can choose to stand firm on what is suggested or recommended in the guidance especially if incentivized by big pharma influence vs being fair with regard to evidence presented that might validate another form of data interpretation. This level of subjective choice creates opportunity for undue influence. For NWBO that apparently was just not worth the risk. Best wishes.